Back to Trades
Gentry Leesa
Chief Clinical OfficerCIK 0002013097
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Gentry Leesa, Chief Clinical Officer, has disclosed $126.0K in transactions — all concentrated in RenovoRx, Inc. (RNXT). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Apr 7 | RNXT RenovoRx, Inc. | Gentry Leesa | Chief Clinical Officer | Award | $126.0K |
1 filing